Clinical Trial

Can Adipose Derived Regenrative Cells be Used for Treating Erectile Dysfunction After Radical Prostatectomy

Completed Phase 2
View on ClinicalTrials.gov →
Summary
The goal of this study was to investigate if adipose derived regenerative cells can be used as a treatment for erectile dysfunction following radical prostatectomy. 70 participants were enrolled in the study and was performed as a double- blinded study. 35 participants in the active study arm recieved an injection into the penis of adipose derived regenerative cells, while the participants of the placebo arm recieved a placebo injection. All 70 participants undervent liposuccion of the abdomen to harvest the adipose derived regenerative cells, and the 35 participants in the active study arm recieved their own regenerative cells. All participants answered the questionnaires International-Index-of- Erectile function 5 and Erection Hardness Scale before treatment and after 1,3,6 and 12 months. These data was used to evaluate the effect of one injection of adipose derived regenerative cells.
Trial Details
NCT Number NCT07355530
Lead Sponsor Odense University Hospital
Collaborators: University of Southern Denmark
Conditions ED, Adipose Derived Stem Cells
Enrollment 70 participants
Start Date 2018-01-20
Primary Completion 2021-03-03 (estimated)
Study Completion 2021-03-03 (estimated)
Updated on ClinicalTrials.gov 2026-01-21